End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
78.4 TWD | +0.51% | +1.03% | -2.49% |
Business Summary
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cancer Drugs
44.1
%
| 2,970 | 58.7 % | 2,430 | 44.1 % | -18.17% |
Anti-infective Drugs
18.4
%
| - | - | 1,013 | 18.4 % | - |
Invest
14.8
%
| - | - | 814 | 14.8 % | - |
Export Sales and OEM
14.5
%
| - | - | 797 | 14.5 % | - |
Medical Insurance
7.0
%
| 179 | 3.5 % | 386 | 7.0 % | +115.77% |
Other
1.2
%
| 283 | 5.6 % | 65 | 1.2 % | -76.87% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Taiwan
87.9
%
| 4,596 | 90.8 % | 4,841 | 87.9 % | +5.33% |
Other Countries
7.2
%
| 466 | 9.2 % | 399 | 7.2 % | -14.37% |
America
4.8
%
| - | - | 266 | 4.8 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sara Hou
CEO | Chief Executive Officer | - | 17/04/22 |
Guo Jiang Zhang
DFI | Director of Finance/CFO | - | 30/12/15 |
Shu Fen Huang
CMP | Compliance Officer | - | 17/04/22 |
Nai Wei Liu
ADM | Chief Administrative Officer | - | 03/12/18 |
Shih-Chou Chen
IRC | Investor Relations Contact | - | - |
Jung Liang Kao
AUD | Comptroller/Controller/Auditor | - | 25/03/21 |
Wen Po Huang
PRN | Corporate Officer/Principal | - | 03/11/21 |
Jen-Yang Chang
HRO | Human Resources Officer | - | 30/04/19 |
Shu-Wen Wang
AUD | Comptroller/Controller/Auditor | - | 12/08/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Wen Hua Chang
BRD | Director/Board Member | - | 23/07/95 |
Hsiu Chi Chang
BRD | Director/Board Member | - | 23/06/16 |
Tzu Chiang Yang
BRD | Director/Board Member | 68 | 23/06/16 |
Tien Fu Lin
BRD | Director/Board Member | - | 23/06/16 |
Chuan Lin
CHM | Chairman | 72 | 21/11/18 |
Tui Tsai
BRD | Director/Board Member | - | 23/06/16 |
Ming-Ling Hsueh
BRD | Director/Board Member | 68 | 23/06/16 |
Ying Ying Liao
BRD | Director/Board Member | - | 23/06/16 |
Carl Hsiao
BRD | Director/Board Member | - | 25/03/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 248,650,000 | 200,715,959 ( 80.72 %) | 0 | 80.72 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.49% | 601M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 4105 Stock
- Company TTY Biopharm Company Limited